New research has confirmed that automated insulin delivery (AID) systems are both safe and effective for older adults with ...

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...

In an AID system, a sensor attached to the arm or belly continuously monitors blood sugar levels and communicates that data to a wearable insulin pump, which then automatically adjusts insulin dosing ...

Tandem Diabetes Care announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in ...

A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) ...

A randomized study from Insulet of adults and children with Type 1 diabetes found that moving from multiple daily injections ...

The Control-IQ+ algorithm enables AID in conjunction with Tandem’s t:slim X2 and Mobi insulin pumps and a compatible continuous glucose monitor (CGM). The updated algorithm allows for a wider ...

A year to the day after declaring the FDA’s clearance of its automated insulin pump, Sequel Med Tech announced that its first connected continuous glucose monitor will be Abbott’s FreeSty | Greenlit ...

Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for ...

Automated insulin delivery systems are safe, effective, and well-received by older adults with type 1 diabetes, challenging stereotypes about technology use in this population.